Do You Lose More Weight with Semaglutide or Tirzepatide?

Last reviewed: June 9, 2026

Last updated: June 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Clinical trials show that tirzepatide users lose more weight on average than semaglutide users—but individual results vary significantly based on genetics, metabolism, and how your body responds to GLP-1 therapy. Understanding the differences between these two medications can help you make an informed choice about which approach aligns with your weight loss goals.

How Tirzepatide and Semaglutide Work Differently

Semaglutide activates one hormone receptor called GLP-1, which signals your brain that you are full and reduces hunger. This single-pathway approach has helped millions of people reduce food intake and lose weight steadily over time. The medication also slows stomach emptying, which keeps you satisfied longer after eating.

Tirzepatide activates two hormone receptors—both GLP-1 and GIP—making it a dual-action compound. By targeting two pathways simultaneously, tirzepatide may create a stronger appetite-suppression signal and improve blood sugar control more comprehensively. This dual mechanism is the primary reason why tirzepatide often produces larger weight reductions in clinical settings.

Weight Loss Outcomes: Clinical Trial Comparisons

In the SUSTAIN trial series, semaglutide at the highest doses produced weight loss ranging from 10% to 18% of body weight over 68 weeks of treatment. These results represent meaningful change for most patients and were substantially better than diet and exercise alone. Semaglutide's effectiveness is well-established across multiple populations and age groups.

Tirzepatide demonstrated even larger reductions in major clinical trials, with participants losing 20% to 22% of body weight at the highest doses over similar timeframes. The SURMOUNT trial series showed that tirzepatide consistently outperformed semaglutide when both were studied head-to-head in similar patient populations. However, not every patient experiences maximal weight loss, and individual responses depend on factors like starting weight, lifestyle, and genetic predisposition.

Genetic Factors That Influence Your Personal Response

Your genes control how efficiently your body produces and responds to GLP-1 and GIP hormones. Some people carry genetic variants that make them naturally better responders to GLP-1 therapy, while others may need dual-pathway activation to see significant results. The PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to reveal how your unique genetic profile influences weight loss medication effectiveness.

Key genetic markers like GLP1R rs6923761 and GIPR rs1800437 directly affect how your cells respond to these medications. If your genetic test shows you have favorable variants in the GLP1R pathway, semaglutide alone might deliver excellent results. Conversely, if your genetic profile suggests weaker GLP-1 signaling or stronger GIP involvement, tirzepatide's dual-action approach could be more effective for you.

Side Effects and Tolerability Differences

Both medications work by slowing digestion and reducing appetite, so nausea, constipation, and mild diarrhea are common early side effects with either choice. Most patients adapt within 2–4 weeks as their body adjusts to the medication. Starting at lower doses and increasing gradually minimizes discomfort while your system accommodates the new hormone signaling.

Tirzepatide's dual-pathway activation can cause slightly more gastrointestinal effects in some users compared to semaglutide, though serious adverse events are rare in either case. Side effect severity is highly individual and often depends on dose escalation speed and how your specific genetic makeup influences GIP receptor sensitivity. PlexusDx healthcare providers work with you to adjust dosing schedules and manage any uncomfortable symptoms.

Choosing Between Semaglutide and Tirzepatide at PlexusDx

PlexusDx offers compounded semaglutide injection starting at $149/month and compounded tirzepatide injection starting at $249/month—with the same price regardless of your dose level, so your dose may need to go up but your price won't. Both medications are sourced from licensed 503A compounding pharmacies and shipped to all 50 states without requiring insurance or a membership fee. Adding the Precision Peptide Genetic Test for $99 after your first month of treatment reveals which medication and which pathways your body is optimized to respond to.

If you want to start with a proven single-pathway option and monitor results, semaglutide is an excellent entry point. If clinical trial data suggesting superior weight loss appeals to you, or if genetic testing indicates weaker GLP-1 responsiveness, tirzepatide may be the better fit. PlexusDx clinicians review your health history, goals, and genetic insights to recommend the approach most likely to work for your body.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will I definitely lose more weight on tirzepatide than semaglutide?

Clinical trials show tirzepatide produces greater average weight loss, but individual results vary widely based on genetics, adherence, and lifestyle. Some patients respond excellently to semaglutide alone, while others need tirzepatide's dual-pathway approach. The PlexusDx Precision Peptide Genetic Test helps predict which mechanism your body will respond to most effectively.

What does the dual GLP-1 and GIP activation in tirzepatide actually do?

GLP-1 signals fullness and reduces appetite; GIP improves insulin secretion and may enhance fat metabolism. Together, they create stronger appetite suppression and better blood sugar control than GLP-1 alone. This dual mechanism is why tirzepatide users typically see faster and larger weight reductions in published trials.

How much does tirzepatide cost at PlexusDx, and does price change with dose increases?

PlexusDx tirzepatide injection starts at $249/month flat and remains $249/month regardless of dose level—your dose may go up, but your price won't. The medication is compounded by licensed 503A pharmacies and shipped to all 50 states without insurance. HSA and FSA funds are also accepted.

Are there significant side effect differences between semaglutide and tirzepatide?

Both cause similar early side effects like nausea and digestive changes as your body adjusts. Tirzepatide's dual activation may cause slightly more GI effects in some users, but serious adverse events are rare with either medication. Side effects typically resolve within weeks, and PlexusDx providers help manage any discomfort through dose adjustment.

How can genetic testing help me decide between semaglutide and tirzepatide?

The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, MC4R, and 10 other pathways to reveal how your body naturally responds to appetite-control hormones. Strong GLP-1 signaling suggests semaglutide may work well; weaker variants or strong GIP involvement suggest tirzepatide's dual approach could be more effective for your genetics.

Related Reading

• Tirzepatide Vs Semaglutide For Weight Loss
• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.